A brief history of immunotoxicology and a review of the pharmaceutical guidelines

International Journal of Toxicology

Volumn 23, Issue 2, 2004, Pages 83-90

  Dean, Jack H ^a,b  

^a Sanofi Synthelabo   (United States)

^b Sanofi Research Division   (United States)

Author keywords

History; Immunotoxicology; Methods Development; Pharmaceutical Guidelines; Validation

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BENZO[A]PYRENE; CARBAMATE INSECTICIDE; CYCLOPHOSPHAMIDE; DIETHYLSTILBESTROL; INDOMETACIN; MERCURIC CHLORIDE; PHORBOL 13 ACETATE 12 MYRISTATE;

CHEMICAL ANALYSIS; ENVIRONMENTAL HEALTH; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTOXICOLOGY; MEDICAL SOCIETY; NONHUMAN; ORGANIZATION; PRACTICE GUIDELINE; REVIEW; TOXICOLOGY; VALIDATION PROCESS;

AUTOBIOGRAPHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; IMMUNE SYSTEM; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PORTRAITS; PRACTICE GUIDELINES; TOXICITY TESTS; TOXICOLOGY;

EID: 2642514216     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810490435596     Document Type: Review

References (48)

1. Berlin, A., J. Dean, J. Draper, E. M. B. Smith, and F. Spreafico. 1987. Synopsis, conclusions, and recommendations. In Immunotoxicology, ed. A. Berlin, J. Dean, M. Draper, E. M. B. Smith, and F. Spreafico, xi-xxvii. Dordrecht: Martinus Nijhoff.
2. Boorman, G. A., M. I. Luster, J. H. Dean, and R. E. Wilson. 1980. The effects of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J. Reticuloendothelial Soc. 28:547-560.
3. Boorman, G. A., M. I. Luster, J. H. Dean, and R. W. Luebke. 1982. Effect of indomethacin on the bone marrow and immune system of the mouse. J. Clin. Lab. Immunol. 7:119-126.
4. Cornacoff, J. B., L. D. Lauer, R. V. House, A. N. Tucker, L. M. Thurmond, J. G. Vos, P. K. Working, and J. H. Dean. 1988. Evaluation of the immunotoxicity of beta-hexachlorocyclohexane (β-HCH). Fundam. Appl. Toxicol. 11:293-299.
5. Dean, J. H., J. R. Hincks, and B. Remandet. 1998. Immunotoxicology assessment in the pharmaceutical industry. Toxicol. Lett. 102-103:247-255.
6. Dean, J. H., R. V. House, and M. I. Luster. 2001. Immunotoxicology. In Principles and methods of toxicology, 4th ed., ed. A. Wallace Hayes, 1415-1450. Philadelphia: Taylor and Francis.
7. Dean, J. H., L. D. Lauer, M. J. Murray, M. I. Luster, D. Neptun, and D.O Adams. 1986a. Studies of macrophage function using markers for stages of activation and resistance to Listeria monocytogenes in mice exposed to diethylstilbestrol. Cell. Immunol. 102:315-322.
8. Dean, J. H., M. I. Luster, G. A. Boorman, L. D. Lauer, and E. C. Ward. 1983. Immunotoxicity of tumor promoting environmental chemicals and phorbol diesters. In Advances in immunopharmacology 2, ed. J. W. Hadden, 23-31. Oxford, New York: Pergamon Press.
9. Dean, J. H., M. I. Luster, G. A. Boorman, R. W. Luebke, and L. D. Lauer. 1980. Effects of adult exposure to diethylstilbestrol in the mouse: Alterations in tumor susceptibility and host resistance parameters. J. Reticuloendothelial. Soc. 28:571-583.
10. Dean, J. H., M. I. Luster, G. A. Boorman, M. L. Padarathsingh, and R. W. Luebke. 1981. Host resistance models as endpoints for assessing immune alterations following chemical exposure: Studies with diethylstilbestrol, cyclophosphamide and 2,3,7,8-tetrachlorodibenzo-p-dioxin. In The biological relevance of immunosuppression induced by therapeutic and environmental agents, ed. J. H. Dean and M. L. Padarathsingh, 233-255. New York: Van Norstrand Reinhold.
11. Dean, J. H., M. J. Murray, E. C. Ward, L. D. Lauer, and R.V. House. 1985. Mechanisms of dimethylbenzanthracene induced immunotoxicity. Clin. Physiol. Biochem. 3:98-110.
12. Dean, J. H., M. L. Padarathsingh, and T. R Jerrells. 1979a. Assessment of immunobiological effects induced by chemicals, drugs or food additives. I. Tier testing and screening approach. Drug Chem. Toxicol. 2:5-17.
13. Dean, J. H., M. L. Padarathsingh, T. R. Jerrells, L. Keys, and J. W. Northin. 1979b. Assessment of immunobiological effects induced by chemicals, drugs or food additives. II. Studies with cyclophosphamide. Drug Chem. Toxicol. 2:133-153.
14. Dean, J. H., and B. Remandet. 1997. Integration of immunotoxicology evaluation in drug development. Drug Information J. 31:1347-1356.
15. Dean, J. H., E. C. Ward, M. J. Murray, L. D. Lauer, R. V. House, W. S. Stillman, T. A. Hamilton, and D.O. Adams. 1986b. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. II. Altered cell-mediated immunity and tumor resistance. Int. J. Immunopharmacol. 8:189-198.
16. Dieter, M. P., M. I. Luster, G. A. Boorman, C. W. Jameson, J. H. Dean, and J. W. Cox. 1983. Immunological and biochemical responses in mice treated with mercuric chloride. Toxicol. Appl. Pharmacol. 68:218-228.
17. Exon, J. H., P. A. Talcoss, and L. D.Koller. 1985. Effect of lead, polychlorinated biphenyls, and cyclophosphamide on rat natural killer cells, interleukin-2, and antibody synthesis, Fundam. Appl. Toxicol. 5:158-64.
18. Goldsby, R. A., T. J. Kindt, and B. A. Osborne. 2000. Overview of the immune system. In Immunology, 4th ed., 3-26, New York: W. H. Freeman and Company.
19. Hastings, K. L. 2002. Implications of the new FDA/CDER Immunotoxicology Guidance for Drugs. Int. Immunopharmacol. 2:1613-1618.
20. Hastings, K. L., J. T. Tulis, and J. H. Dean. 1988. Production and characterization of a monoclonal antibody to aflatoxin B-2. J. Agric. Food Chem. 36:404-408.
21. Holsapple, M. P., J. G. Karras, J. A. Ledbetter, G. L. Schieven, S.W. Burchiel, D. R. Davila, A. R. Schatz, and N. E. Kaminski. 1996. Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers. Annu. Rev. Pharmacol. Toxicol. 36:131-159.
22. House, R. V., and J. H. Dean. 1987. Structural requirements for suppression of cytotoxic T-lymphocyte induction by polycyclic compounds. In Vitro Toxicol. 1:149-162.
23. House, R. V., L. D. Lauer, M. J. Murray, and J. H. Dean. 1987. Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2. Int. J. Immunopharmacol. 9:89-97.
24. House R. V., L. D. Lauer, M. J. Murray, P. T. Thomas, J. P. Ehrlich, G. R. Burleson, and J. H. Dean. 1990. Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Toxicol. Environ. Health 31:203-215.
25. House, R. V., M. J. Pallardy, J. B. Cornacoff, L. M. Thurmond, and J. H. Dean. 1989a. Suppression of cytolytic function in murine lymphocyte exposed to 1,4-bis[(2-aminoethyl)amino]-5,8 dihydroxy-9,10-anthracenediodihydrochloride (AEAD): Inhibition of proliferation by cytotoxic T-lymphocyte precursors. Int. J. Immunopharmacol. 11:301-308.
26. House, R. V., M. J. Pallardy, and J. H. Dean. 1989b. Suppression of murine cytotoxic T-lymphocyte induction following expsosure to 7,12-dimethylbenz-[a]anthracene: Dysfunction of antigen recognition Int. J. Immunopharmacol. 11:207-215.
27. Karol, M. H., and R. Jin. 1992. Mechanisms of immunotoxicity to isocyanates. In Frontiers in molecular toxicology, ed. L. J. Marnett, 55-61. Washington, DC: American Chemical Society.
28. Kerkvliet, N. I., L. B. Steppan, J. A. Brauner, J. A. Dyeo, M. C. Henderson, R. S. Tomar, and D. R. Bunler. 1990. Influence of the AH locus on the humor immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for AH-receptor dependent and AH-receptor independent mechanisms of immunosuppression. Toxicol. Appl. Pharmacol. 105:26-36.
29. Kuper, C. F., J. H. Harleman, H. B. Richter-Reichelm, and J. G. Vos. 2000. Histopathology approaches to detect changes indicative of immunotoxicity. Toxicol. Pathol. 28:454-466.
30. Luster, M. I., G. A. Boorman, J. H. Dean, M. W. Harris, R. W. Luebke, J. E. Thigpen, M. L. Padarathsingh, and J. A. Moore. 1980a. Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8 TCDD. Int. J. Immunopharmacol. 2:301-310.
31. Luster, M. I., G. A. Boorman, J. H. Dean, L. D. Lawson, R. E. Wilson, L. D. Lauer, R. W. Luebke, J. Rader, and M. L. Campbell. 1981a. Increased resistance to Listeria monocytogenes following subchronic cyclophosphamide exposure: Relationship to altered bone marrow function. Cell. Immunol. 65:131-141.
32. Luster, M. I., G. A. Boorman, J. H. Dean, R. W. Luebke, and L. D. Lawson. 1980b. The effect of adult exposure to diethylstilbestrol in the mouse: Alteration in immunological functions. J. Reticuloendothelial. Soc. 28:561-569.
33. Luster, M. I., J. H. Dean, and G. A. Boorman. 1982a. Altered immune functions in rodents treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin, phorbol-12-myristate-13-acetate, and benzo(a)pyrene. In Banbury Report 11. Environmental factors in human growth and development, ed. V. R. Hunt, M. K. Smith, and D. Worth, 199-215. Cold Springs Harbor, NY: Cold Springs Harbor Laboratory.
34. Luster, M. I., J. H. Dean, G. A. Boorman, D. L. Archer, L. Lauer, L. D. Lawson, J. A. Moore, and R. E. Wilson. 1981b. The effects of orthophenylphenol, tris (2,3,dichloropropyl) phosphate and cyclophosphamide on the immune system and host susceptibility of mice following subchronic exposure. Toxicol. Appl. Pharmacol. 58:252-261.
35. Luster, M. I., J. H. Dean, G. A. Boorman, M. P. Dieter, and H. T. Hayes. 1982b. Immune functions in methyl and ethyl carbamate treated mice. Clin. Exp. Immunol. 50:223-230.
36. Luster, M. I., C. Portier, D. G. Pait, K. L. White, Jr., C. Gennings, A. E. Munson, and G. J. Rosenthal. 1992. Risk assessment in immunotoxicology, I. Sensitivity and predictability of immune tests. Fundam. App. Toxicol. 18:200-212.
37. Pallardy, M. J., R. V. House, and J. H. Dean. 1989. Molecular mechanism of 7,12-dimethyl-benz[a]anthracene-induced immunosuppression: Evidence for action via the interleukin-2 pathway. Mol. Pharmacol. 36:128-133.
38. Penninks A., F. Kuper, B. J. Spit, and W. Seinen. 1985. On the mechanism of dialkyltin-induced thymus involution. Immunopharmacology 10:1-10.
39. Putman, E., H. van Loveren, G. Bode, J. H. Dean, K. Hastings, K. Nakamura, F. Verdier, and J. W. van der Laan. 2002. Assessment of the immunotoxic potential of human pharmaceuticals: A workshop report. Drug Inform. J. 36:417-427.
40. Selgrade, M. J., M. J. Daniels, G. R. Burleson, L. D. Lauer, and J. H. Dean. 1988. Effects of 7,12-dimethyl benz[a]anthracene, benzo[a]pyrene, and cyclosporin A on murine cytomegalovirus infection: Studies of resistance mechanisms. Int. J. Immunopharmacol. 10:811-818.
41. Thurmond, L. M., R. V. House, and J. H. Dean. 1991. Disturbance of calcium signaling and phosphoinositide metabolism in murine lymphocytes by 7,12 dimethyl-benzene [a] anthracene. In Vitro Toxicol. 4:217-230.
42. Thurmond, L. M., R. V. House, L. D. Lauer, and J. H. Dean. 1988. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro. Toxicol. Appl. Pharmacol. 93:369-377.
43. Thurmond, L. M., L. D. Lauer, R. V. House, W. S. Stillman, R. D. Irons, W. H. Steinhagen, and J. H. Dean. 1986. Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions. Toxicol. Appl. Pharmacol. 86:170-179.
44. Tian L., and D. A. Lawrence. 1996. Metal-induced modulation of nitric oxide production in vitro by murine macrophages: Lead, nickel, and cobalt utilize different mechanisms. Toxicol. Appl. Pharmacol. 141:540-547.
45. Vos, J. G. 1977. Immune suppression as related to toxicology. CRC Crit. Rev. Toxicol. 5:67-191.
46. Vos, J. G. 1984. Dioxin-induced thymic atrophy and suppression of thymus-dependent immunity. In Danbury Report, Biological mechanisms of dioxin action, vol. 18, ed. A. Poland and R. D. Kimbrough, 401-410, Cold Springs Harbor Laboratory.
47. Ward, E. C., M. J. Murray, L. D. Lauer, R. V. House, R. Irons, and J. H. Dean. 1984. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects of humoral immunity and host resistance. Toxicol. Appl. Pharmacol. 75:299-308.
48. White, K. L., Jr., T. T. Kawabata, and G. S. Ladics. 1994. Mechanisms of polycyclic aromatic hydrocarbon immunotoxicity. In Target Organ Toxicology Series; Immunotoxicology and immunopharmacology, 2nd ed., ed. J. H. Dean, M. I. Luster, A. E. Munson, and I. Kimber, 123-142. New York: Raven Press.